Pathophysiological role of secretory type I and II phospholipase A2 in acute pancreatitis: an experimental study in rats.
BACKGROUND
In human acute pancreatitis two different types of secretory phospholipase A2 (PLA2) have been found.


OBJECTIVE
To analyse the specific pattern of distribution of these PLA2 activities and their pathophysiological role in experimental acute pancreatitis.


METHODS
Catalytic activities of secretory type I (pancreatic) and type II (non-pancreatic) PLA2 and the protein concentration of immunoreactive pancreatic PLA2 (IR-PLA2) in serum and pancreatic tissue of rats with cerulein (mild form) and sodium taurocholate (severe form) induced acute pancreatitis were determined.


RESULTS
Cerulein infusion caused a significant increase in type I PLA2 activity (p < 0.01) and IR-PLA2 protein concentration (p < 0.01) in serum and pancreas, whereas type II PLA2 activity remained unchanged during the 12 hour observation period. Histology showed no significant tissue destruction. In sodium taurocholate induced acute pancreatitis type II PLA2 activity significantly increased, reaching values over 10-fold higher than controls (p < 0.01), whereas IR-PLA2 protein concentration and type I PLA2 activity were only marginally increased. In this severe model of acute pancreatitis significantly lower values were detected than in the control pancreas (p < 0.002) for PLA2 activity and IR-PLA2 protein concentration. Histology showed parenchymal and fat necroses with haemorrhage, oedema, and inflammatory cell infiltration.


CONCLUSIONS
Type I PLA2 activity is dependent on the IR-PLA2 protein concentration in serum and pancreatic tissue. The type II PLA2 activity is not stimulated by cerulein, which indicates an extra-acinar origin of this enzyme. Type II PLA2 activity is significantly increased in sodium taurocholate induced acute pancreatitis indicating its role in the local necrotising process and involvement in the systemic effects in severe acute pancreatitis.
Uhl
W
W
Department of Visceral and Transplantation Surgery, University of Bern, Switzerland.
Schrag
H J
HJ
Schmitter
N
N
Nevalainen
T J
TJ
Aufenanger
J
J
Wheatley
A M
AM
Büchler
M W
MW
D000208:Acute Disease; D000818:Animals; D002384:Catalysis; D002108:Ceruletide; D005260:Female; D010179:Pancreas / Q000201:enzymology / Q000473:pathology; D010195:Pancreatitis / Q000139:chemically induced / Q000201:enzymology* / Q000473:pathology; D010741:Phospholipases A / Q000097:blood / Q000378:metabolism*; D054467:Phospholipases A2; D051381:Rats; D017208:Rats, Wistar; D013656:Taurocholic Acid
D013656:Taurocholic Acid; D002108:Ceruletide; D010741:Phospholipases A; D054467:Phospholipases A2